Barr Sued Over Plan For Schizophrenia Drug

Law360, New York (March 21, 2007, 12:00 AM EDT) -- Japanese drug maker Otsuka Pharmaceutical Co. Ltd. has filed a patent infringement lawsuit against Barr Pharmaceuticals Inc. over its plan to manufacture a generic version of Otsuka’s schizophrenia drug, Abilify.

Otsuka filed the lawsuit in response to Barr’s abbreviated new drug application, filed in November with the U.S. Food and Drug Administration. The ANDA, which seeks permission to make the generic version, claims Otsuka’s patent for Abilify is invalid.

The lawsuit was filed on March 16 with the U.S. District Court for the District of New...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.